Reckitt Can't Escape Antitrust Case Over 'Product-Hopping'
By Khadijah M. Britton ( December 4, 2014, 7:01 PM EST) -- A Pennsylvania federal judge on Wednesday trimmed a multidistrict class action against Reckitt Benckiser Inc. but said direct purchasers of the drug sufficiently backed their claim that the drugmaker used an anti-competitive "product-hopping" scheme to keep generic rivals to its opiate addiction treatment Suboxone off the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.